Aggregator

Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health

1 month ago

As biotech and other sectors of the life sciences industry espouse cautious optimism for a stabler financing environment in 2026, the steady influx of new funds in the space suggests things are trending in a better direction so far. The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its fifth and biggest fund to date.

Fraiser Kansteiner